openPR Logo
Press release

Autoimmune Treatment Market North America Leads the Global Autoimmune Treatment Market, Due to Aging Population, High Incidences of Autoimmune Diseases

03-05-2019 05:33 AM CET | Health & Medicine

Press release from: P&S Intelligence

Autoimmune Treatment Market North America Leads the Global

The global autoimmune treatment market is growing significantly due to increasing incidences of autoimmune diseases, up surging healthcare expenditure, and advancements in the technologies for the development of autoimmune diseases therapeutics. Autoimmune diseases are chronic in nature and do not have permanent treatment. This creates ample growth opportunity for the autoimmune treatment market, to grow at a considerable rate in the coming years. The advanced research and development facilities, and new product developments by the companies are propelling the demand for cost effective treatment of autoimmune diseases.

Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/autoimmune-treatment-market

The abnormal response of immune system leads to autoimmune disorders. Normally, the body’s immune system provides protection against foreign bodies or harmful substances. However, in the autoimmune disorders, the immune system fails to differentiate between a healthy tissue or cell and a harmful substance (antigen), and destroys the normal tissues. Autoimmune diseases have high prevalence among female children and women. There are more than 80 prevailing autoimmune diseases. Some of the most common autoimmune disorders include psoriasis, multiple sclerosis, rheumatoid arthritis, type 1 diabetes, systemic lupus erythematosus, inflammatory bowel disease, and Addison’s disease.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/autoimmune-treatment-market/report-sample

Based on technology, the autoimmune treatment market is segmented as bridge therapy, phototherapy, topical therapy, fecal bacteriotherapy, recombinant technology, diseases-modifying antirheumatic drugs, helminthic therapy, and hematopoietic stem cell transplantation. And based on product types, the autoimmune treatment market can be categorized as diagnostic equipment, drugs, therapeutic equipment, and other products. The drugs category leads the global autoimmune treatment market, in terms of revenue. Drugs are further classified as methotrexate, non-steroidal anti-inflammatory drugs, corticosteroids, glucocorticoids, 5-aminosalicylic acid, and others.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=autoimmune-treatment-market

Geographically, North America leads the global autoimmune treatment market, due to aging population, high incidences of autoimmune diseases, increased healthcare expenditure, and excessive R&D investment for the development of drugs for autoimmune diseases. Asia-Pacific is the fastest growing region in the global autoimmune treatment market. The major reasons for the fastest growth in the region are increasing healthcare expenditure and improving healthcare infrastructure. Moreover, the autoimmune treatment market is growing, due to increasing disposable income and large population suffering from autoimmune diseases in the emerging countries, such as India and China.

Some of the major players operating in the global autoimmune treatment market are Abott, Bristol-Myers Squibb Company, Amgen Inc., Pfizer Inc., Bayer AG, F. Hoffmann-La Roche AG, Eli Lilly and Company, Novartis AG, Johnson & Johnson Services Inc., Merck & Co. Inc., Sanofi, GlaxoSmithKline PLC, Biogen, Boehringer Ingelheim GmbH, AstraZeneca PLC, and Astellas Pharma Inc.

About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoimmune Treatment Market North America Leads the Global Autoimmune Treatment Market, Due to Aging Population, High Incidences of Autoimmune Diseases here

News-ID: 1631156 • Views: 180

More Releases from P&S Intelligence

New feature of Female Fertility and Pregnancy Rapid Test Market Size, Strategies …
The global market is increasing, due to growing female geriatric population and increasing incidence of uterine malformations. In addition, the growing female infertility cases, increasing cases with abnormal uterine bleeding and growing demand for easy to use at home diagnostic devices are encouraging the growth of the global female fertility and pregnancy rapid test market. Explore Full Report on “Female fertility and pregnancy rapid test Market” at: https://www.psmarketresearch.com/market-analysis/fertility-and-pregnancy-rapid-test-market The information and data
Disposable Medical Sensors Market Insights, Potential Business Strategies, Merge …
The disposable medical sensors market is witnessing a trend of home healthcare services due to the rising healthcare costs and incidence of hospital-acquired infections. Technological advancements have played a major role in improving the diagnostics field by giving rise to its subset, point-of-care diagnosis. Portable devices for home healthcare use sensors for the detection of specified parameters and offer immediate results. The key manufacturing companies are increasingly investing in light
Bottled Water Market Professional Survey Report, Industry Growth, Shares, Market …
Drinking water packed in glass or plastic bottles is referred as bottled water. Bottled water may or may not be carbonated. Bottled water continues to be a popular choice of consumers despite the carbonated soft drinks having established. Water sold in large bottles holding one to 2.5 gallons is relatively cheaper compared to carbonated water sold at higher prices per gallon. Increasing inclination of consumers from high calorie carbonated soft
Aquaculture Market Outlook, Opportunities, Challenges, Trends, Size and Growth, …
Aquaculture involves cultivation of brackish water, marine water, and freshwater organisms such as carps, crustaceans, mollusks and salmon, under organized climatic conditions. It involves the farming of fish and other aquatic species. The global aquaculture market is segmented on the basis of culture environment, and product.. On the basis of culture environment, the global aquaculture market can be segmented into freshwater, marine water, and brackish water. The market by product segment

All 5 Releases


More Releases for Autoimmune

Autoimmune Disease Therapeutics Market Boost due to increase in incidence of aut …
According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5185?utm_source=openpr&utm_medium=Niranjan Autoimmune disease therapeutics include
Autoimmune Disease Diagnostics Market: Rise in Autoimmune Diseases, alongside Gr …
Global Autoimmune Disease Diagnostics Market: Snapshot The global autoimmune disease diagnostics market is expected to witness a modest growth in the coming years on account of the growing incidences of autoimmune diseases among people worldwide. Efficient autoimmune disease diagnostics has become absolutely essential to tackle this issue. Governments across nations are also increasing their spending towards healthcare in light of these growing incidences of autoimmune diseases. This has also resulted in
Autoimmune Disease Diagnostics Market Growth Analysis 2023
Despite its vendor landscape being highly consolidated, intense rivalry prevails among key players in The Global Autoimmune Disease Diagnostics Market. According to Transparency Market Research (TMR), the top four companies held over 50% of the global autoimmune disease diagnostics market in 2014. Among the leading enterprises, F. Hoffmann-La Roche Ltd. held the dominant share of over 17% in the market in the same year. In response to the increasing demand for
Autoimmune Disease Diagnostics Market: Growing Awareness Among People About Auto …
The global autoimmune disease diagnostics market is expected to witness a modest growth in the coming years on account of the growing incidences of autoimmune diseases among people worldwide. Efficient autoimmune disease diagnostics has become absolutely essential to tackle this issue. Governments across nations are also increasing their spending towards healthcare in light of these growing incidences of autoimmune diseases. This has also resulted in the research and development of
Global Autoimmune Treatment Market Research Report 2017
Global Autoimmune Treatment Industry 2017 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2017-2020. The research report on global Autoimmune Treatment market offers an in-depth analysis, presenting insights into the key growth factors, which are estimated to encourage growth of the global market. In addition, the research study throws light on the drivers, barriers, latest opportunities, current trends, and the technological developments
Autoantibody Diagnostics in Autoimmune Liver Diseases
ORGENTEC Diagnostika (www.orgentec.com) has developed four new laboratory tests for the diagnosis of autoimmune liver diseases. These tests are now on the market. They are based on ELISA technology and were specifically developed for fully automated analysis with Alegria®. The new tests systems, called Anti-Sp100, Anti-gp210, Anti-LKM-1, and Anti-SLA, reliably detect specific autoantibodies that are characteristic of various autoimmune liver diseases. The tests thus also allow for reliable differentiation between these